It was found that adding NB-UVB light therapy to ruxolitinib (Opzelura) 1.5% cream helped many vitiligo patients who did not respond early to treatment achieve faster and more noticeable skin ...

Insurance coverage remained historically high, though it declined slightly from its peak. In 2024, 91.8% of the population was insured, down from 92.5% in 2023. Private health insurance enrollment ...

SB 41 prohibits spread pricing, requires PBMs and group purchasing organizations to pass through 100% of manufacturer rebates ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

Kristine Rawlings, PharmD | Authors | Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.